Analyst Ratings for Corcept Therapeutics (cort)
cort Rating Summary
cort Price Target Summary
- Highest: $165.00 (Piper Sandler)
- Lowest: $50.00 (Truist Securities)
- Average: $108.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$108.67 (-5.1%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
Avg. $ Target:
$108.67 (-5.1%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/27/2026 | Wolfe Research | Kalpit Patel | Downgrade | Underperform (Peerperform) |
50.00 (N/A) |
96.66 (114.47) |
18.43% | Details |
| 5/13/2026 | UBS | Ashwani Verma | Upgrade | Neutral (N/A) |
72.00 (44.00) |
51.20 (114.47) |
123.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
